slower99
An appealing speculation, well done to you. But I think another possibility could just as easily be the trigger.
Knowing the company cash position which is no secret anywhere, it's inconceivable that other big suitors interested in stem cells for their platforms, were not sniffing around for some action. That being the case, getting this stake hold at a very modest price (considering target valuations currently hawked around) with the added bonus of ROFR protection from your competitors, would be too good to refuse all things considered - if you were serious about the MSC space of course. That would definitely be my call in their position.
Further thoughts on Celgene deal, page-9
-
- There are more pages in this discussion • 75 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.12 |
Change
0.025(2.29%) |
Mkt cap ! $1.255B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $2.814M | 2.556M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 21881 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 30926 | 17 |
View Market Depth
| Last trade - 15.01pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |